2nd Annual Bispecifics in Discovery & Development Congress

Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.

New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.  

Key Speakers Include:  

• Tristan Vaughan, Vice President, AstraZeneca 
• John McCafferty, Chief Executive Officer, IONTAS Pharmaceuticals 
• Surinder Kaur, Director, Genentech 
• Kristin Brown, Director, GlaxoSmithKline 

VIEW AGENDA: https://bit.ly/30vvvXx

Part of the Biologics Series, it is co-located the 13th Annual Proteins & Antibodies Congress and the 7th Annual Peptides & Oligonucleotides Congress. 

2020 Live Webinar:

“Bispecific Antibodies Targeting The Innate Immune Checkpoint CD47

Presented by Nicolas Fischer, Chief Executive Officer, Light Chain Bioscience

Tuesday 21st January 2020 | 2PM UK GMT

REGISTER FOR FREE: https://bit.ly/2sAyHUM

Go Social: Join our Proteins Network on LinkedIn, follow us on Twitter at @biologicsconf and join the conversation using the hashtag #Biologics20

For more information about the event, please contact Bradley Copeman at b.copeman@oxfordglobal.co.uk or visit the website: https://bit.ly/2RlkT9v

Date: 27 - 29 April 2020

Location: London, UK